PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Latest Information Update: 14 Oct 2024
At a glance
- Drugs Everolimus (Primary)
- Indications Astrocytoma; Glioma
- Focus Therapeutic Use
- Acronyms PNOC 001
- 09 Oct 2024 Status changed from active, no longer recruiting to completed.
- 19 Jul 2023 Planned End Date changed from 30 Apr 2024 to 31 Jul 2024.
- 29 Jan 2021 Planned End Date changed from 31 Jan 2028 to 30 Apr 2024.